Rare Diseases & Orphan drugs

Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drug can be defined as the one that is used to treat an orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively. 

  • Craniofacial Morphogenesis
  • Diverse Immunotherapy Approaches
  • T cell immunotherapy
  • Gene, stem cell and future therapies for orphan diseases
  • Rare Diseases and Regenerative Medicine

Related Conference of Rare Diseases & Orphan drugs

November 13-14, 2017

19th World Congress on Biotechnology

Osaka, Japan
December 04-05, 2017

2nd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
December 11-12, 2017

3rd World Bio Summit & Expo

Dubai, UAE
March 5-7, 2018

20th Global Congress on Biotechnology

London, UK
May 14-15, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
July 9-10, 2018

8th World Congress on Plant Science & Genomics

Sydney, Australia
August 20-21, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
SEPTEMBER 24-25, 2018

5th World Congress on HUMAN GENETICS

BERLIN, GERMANY
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism 2018

Philadelphia, USA
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, USA
October 11-12, 2018

21st Euro Biotechnology Congress

Moscow, Russia
November 2-3, 2018

International Congress & Expo on Genomics and Bioinformatics

Columbus, Ohio, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Stem Cell Research

Atlanta, Georgia, USA

Rare Diseases & Orphan drugs Conference Speakers

Recommended Sessions

Related Journals

Are you interested in